<DOC>
	<DOCNO>NCT00002094</DOCNO>
	<brief_summary>To determine time course development resistance atevirdine mesylate ( U-87201E ) patient HIV isolate show vitro resistance zidovudine ( AZT ) . To determine genotype change HIV reverse transcriptase associate vitro AZT resistance U-87201E . To determine genotype phenotype effect treatment nondideoxynucleoside agent alteration HIV-1 population associate vitro AZT resistance . To determine whether serial passage patient pre-drug HIV isolate presence U-87201E generate resistant mutant may subsequently emerge patient .</brief_summary>
	<brief_title>Prospective Open-Label Study Emergence Drug Resistance Patients Infected With HIV-1 Who Are Taking Oral U-87201E</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atevirdine</mesh_term>
	<criteria>Inclusion Criteria Patients must : Enrollment protocol RV43 ( AZT resistance study ) . Development primary RV43 study endpointopportunistic infection . HIV isolate AZT IC50 &gt; 50 time sensitive type strain . Able swallow tablet without difficulty . Normal QTc interval EKG . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Clinically significant hypersensitivity piperazine type drug ( Antepar , Stelazine ) . Severe uncontrollable diarrhea vomit know malabsorption . Symptomatic hyperlipidemia . Concurrent Medication : Excluded : Other experimental drug . AZT , ddI , ddC , foscarnet , immunomodulators agent primary antiretroviral activity ( exemption principal investigator permit ) . Patients follow prior condition exclude : History clinically significant cardiovascular disease nervous system muscle disease , include seizure , peripheral neuropathy , dementia , motor dysfunction . Prior Medication : Excluded : Experimental drug within 4 week prior study entry .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 1993</verification_date>
	<keyword>Virus Replication</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>